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Cyclic ADP-ribose metabolism in rat kidney: High capacity for synthe-
sis in glomeruli. Recent discovery of cyclic ADP-ribose (cADPR) as an
agent that triggers Ca2 release from intracellular stores, through ryano-
dine receptor channel, is an important new development in the investiga-
tion of intracellular signaling mechanisms. We determined the capacity of
kidney and its components for synthesis of cADPR from f3-NAD, that is
catalyzed by enzyme ADP-ribosyl cyclase, and enzymatic inactivation that
is catalyzed by cADPR-glycohydrolase. Little or no activity of ADP-ribosyl
cyclase was found in extracts from the whole rat kidney, renal cortex, outer
and inner medulla. On the other hand, incubation of p-NAD with similar
extracts from rat liver, spleen, heart, and brain resulted in biosynthesis of
cADPR. In addition, extracts from suspension of proximal tubules or
microdissected proximal convoluted tubules virtually lacked ADP-ribosyl
cyclase activity. In sharp contrast to proximal tubules and cortex, extracts
from glomeruli had high ADP-ribosyl cyclase activity, similar to that found
in non-renal tissues. Authenticity of cADPR biosynthesized in glomeruli
was documented by several criteria such as HPLC analysis, effect of
inhibitors and homologous desensitization of Ca2-release bioassay. On
the other hand, the activity of cADPR-glycohydrolase was similar in
extracts from glomeruli and in extracts from kidney cortex. Mesangial cells
and vascular smooth muscle cells grown in primary culture displayed
considerable ADPR-ribose cyclase activity. Our results show that extracts
from glomeruli, unlike extracts from renal tissue zones and proximal
tubules, have a singularly high capacity for synthesis of cADPR. We
surmise that cADPR-triggered Ca2 '-releasing system can serve as an
intracellular signaling pathway that may be operant in regulations of
glomerular cell functions.
Cyclic ADP-ribose (cADPR) is a recently identified unique
cyclic nucleotide that triggers release of calcium (Ca2) from
intracellular stores through ryanodine receptor/channel (RyR)
(1—3]. It is well established [1, 2] that cADPR is biosynthesized
from 13-NAD by enzymatic reaction catalyzed by ADP-ribosyl
cyclase (ADPR-cyclase). Conversely, another enzyme, cADPR-
glycohydrolase, converts cADPR to inactive non-cyclic adenosine
diphospho ribose (ADPR). It was proposed that cADPR may play
a role as a second messenger that acts via release of Ca2 from its
intracellular stores and represents a novel signaling pathway that
is distinct from the well-established 1 ,4,5-trisphosphate (1P3)-
Ca24 release pathway [1, 2, 4]. The effects of these two agents
upon the release of Ca2 from intracellular vesicles can be
differentiated with the use of specific inhibitors, by homologous
desensitization in sea urchin homogenate Ca2 release bioassay
[1, 21. The properties of cADPR as a specific Ca2-releasing agent
and activities of enzymes that catalyze cADPR metabolism were
first discovered and investigated in depth in invertebrate cells and
tissues, namely sea urchin eggs [5] and ovotestis from mollusk
Aplysia Californica [6]. Subsequently, enzymes of cADPR synthe-
sis and hydrolysis were also found in various vertebrate tissues [7,
8] and cultured cells [9—11], and several types of ADPR-cyclase
from both vertebrate and invertebrate tissues were cloned and
sequenced [12—141. These observations and the widespread occur-
rence of cADPR metabolism in a variety of cell types suggest that
cADPR may have an important function as a novel intracellular
signaling system that regulates various cell functions [1, 2, 4].
With respect of kidney and renal cells, in our previous studies
we found the cADPR metabolic system in LLCPK1 cells [10] and
cultured opossum kidney (OK) cells [111, an observation that
raises the possibility that cADPR plays a role in endocrine and
intracrine regulations of renal cells [15]. Moreover, we observed
that in LLCPK cells the cADPR synthesis, but not hydrolysis, is
stimulated manyfold by preincubation with all-trans-retinoic acid
(atRA), probably via a genomic mechanism [101. In view of these
observations on established renal cell lines [10, 11], we investi-
gated ADPR-cyclase and cADPR-glycohydrolase activities in
extracts from the whole kidney, major zones of kidney paren-
chyma as well as in isolated glomeruli and proximal tubules.
Herein we report that activity of ADPR-cyclase in extracts from
kidney cortex, inner medulla and outer medulla was barely
measurable, whereas in extracts of several non-renal tissues high
activity of cADPR-cyclase was readily detectable. Remarkably, a
high capacity for cADPR synthesis from f3-NAD was found in
isolated glomeruli, but virtually none was found in cortical
proximal tubules. These data provide new fundamental informa-
tion on enzymes of cADPR metabolism in the kidney parenchyma
and reveal that glomeruli are endowed with high ADPR-cyclase
activity, a finding which suggests that cADPR signaling pathway
could play a role in the regulation of glomerular functions.
Methods
Tissues were harvested from adult male Sprague-Dawley rats
(200 to 250 g body wt) and sacrificed under pentobarbital
anesthesia. Kidney, brain, heart, liver, and spleen were quickly
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dissected, chilled, and minced in ice-cold solution containing 0.25
M sucrose, 20 mi Tris-HCI (pH 7.2), 20 pg/.d leupeptin. Tissue
were homogenized (1:4; wtlvol) in Dounce homogenizer using 4
to 5 strokes and centrifuged at 4000 X rpm for 10 minutes at 4°C.
The supernatants, denoted further as "extract," were collected
and used for determination of enzymatic synthesis and hydrolysis
of cADPR. In the present study, only freshly prepared tissue
homogenates were used. The protein content was measured by
the method of Lowry et al [16].
Preparation of glomeruli and proximal convoluted tubules
Glomeruli were prepared with the use of sieving method as
described in detail previously [17]. Briefly, rats were anesthetized
by i.p. injection of pentobarbital sodium (90 mg/kg body wt), and
the kidneys were perfused (10 ml/min) in situ with pre-warmed
(37°C) Hanks' balanced salt solution (HBSS) followed by ice-cold
HBSS. Cortical tissue was finely minced before passing through a
stainless steel sieve (250 m pore size). The resulting suspension
was passed several times through a 22-gauge needle to ensure
complete dispersion and sequentially sieved through nylon mesh
of 390, 250, and 211 .tm pore openings. The cortical suspension
was then centrifuged at 800 x g for five minutes. The pellet was
resuspended in HBSS and passed over a 60 1tm sieve to collect the
glomeruli. Purity of glomeruli was evaluated by microscopic
examination, and counting preparations contained  95% gb-
meruli [17]. Suspension of proximal tubular segments was pre-
pared with the use of a combination of collagenase digestion and
Percoll gradient isolation technique [18].
Microdissection of proximal convoluted tubule segments from
renal cortex was performed as described in our preceding studies
[19, 20]. The protein content was determined by the micro-Lowry
method [21] in an aliquot of microdissected tubular segments, and
specific activities of ADPR-cyclase were expressed relative to
protein. Samples of microdissected tubules of total length about
50 mm were used per one assay.
Determination of ADPR-cyclase and cADPR-glycohydrolase
activities
To measure ADP-ribosyl cyclase, tissue extracts were incubated
with 0.5 mivi I3-NAD, as described in the Figure legends, in a
medium containing 0.25 M sucrose and 20 mivi Tris MC1 (pH 61
7.2) for 60 minutes or as specified in Results section, and the
content of cADPR before and after incubations was determined
using the sea urchin egg homogenate Ca24 release bioassay [4, 8,
10, 11, 22, 23]. The cADPR glycohydrolase was determined by
incubating 50 /LM cADPR with extracts in a medium containing:
0.25 M sucrose and 20 mvi Tris HC1 (pH = 7.4) for 60 minutes, and
cADPR content at times 0 and 60 minutes was determined using
the sea urchin egg homogenate bioassay.
Sea urchin egg homogenate bioassay
Homogenates from sea urchin eggs (Lytechinus pictus) were
prepared as described previously [2, 4, 11, 22, 23]. Frozen
homogenates were thawed in a 17°C water bath and diluted to
1.25% in a medium containing 2 U/ml creatine kinase, 4 mivi
phosphocreatine, 1 mr'i ATP, 3 sg/ml oligomycin, and 3 jsg/ml
antimycin. After preincubation with 3 LM fluo-3 at 17°C for three
hours, fluo-3 fluorescence was monitored at 490 nm excitation and
535 nm emission in a 250 jsl cuvette at 17°C with a circulation
water bath and continuously mixed with a magnetic stirring bar,
using Hitachi spectrofluorimeter (F-2000) [10, 11, 231.
Mesangial cells
Mesangial cells were grown in cell culture from glomeruli that
were isolated from 200 g male Sprague-Dawley rats by differential
sieving [24]. Cell outgrowths were characterized as mesangial cells
by positive immunohistochemical staining for vimentin, smooth
muscle-specific actin, and negative stains for cytokeratins, factor
VIlI-related antigen, and leukocyte common antigen. Cells from
passages 8 to 12 were used in these experiments. Mesangial cells
or vascular smooth muscle cells (VSMC) were harvested [24], and
the extract was prepared similarly as from renal tissue (vide
supra).
Vascular smooth muscle cells
Experiments were performed in vitro using vascular smooth
muscle cells (VSMC) from rat thoracic aorta. Thoracic aorta was
isolated from 200 g male Sprague-Dawley rats, and VSMC were
then outgrowths from explants [25]. Cells were grown in Dulbec-
co's modified minimal essential medium (DMEM) supplemented
with 10% bovine calf serum in a humidified chamber at 37°C in an
atmosphere of 95% air and 5% CO2 until cells reached conflu-
ency. VSMC were characterized as described previously [25] by
positive immunohistochemical staining for smooth muscle actin
and negative stains for cytokeratin and factor Vu-related antigen
(antibodies from Dako Corp., Carpintarie, CA, USA). VSMC
used for experiments were from 4 to 10 passages and were
completely homogenous, as described above.
Preparation of cADPR and NAADP
Authentic cADPR was synthesized enzymatically from f3-NAD
by ADP-ribosyl cyclase from Aplysia Californica, as described
before [23]. Nicotinic acid adenine dinucleotide phosphate
(NAADP) was synthesized from NADP and nicotinic acid via the
pyridine base-exchange enzymatic reaction catalyzed by NAD-
glycohydrolase [24J. The nucleotides were purified by anion-
exchange HPLC [24]. cADPR and NAADP used in all experi-
ments were at least 97% pure as determined by HPLC analysis.
L. Pictus and Aplysia Californica were obtained from Marinus,
Inc. (Long Beach, CA, USA). Fluo-3 was purchased from Molec-
ular Probes; 1P3, oligomycin and antimycin were from Calbio-
chem®. All other reagents, of the highest purity grade available
were supplied from Sigma Co. (St. Louis, MO, USA). When
appropriate, results were evaluated statistically by the Student's
t-test.
Results
Metabolism of cADPR in zones of kidney parenchyma and
non-renal tissues
To determine whether major subdivisions of the kidney contain
activities of the enzymes that synthesize and inactivate cADPR,
ADPR-cyclase and cADPR-glycohydrolase activities were deter-
mined in extracts from renal cortex, outer and inner medulla.
Only a marginal amount of cADPR was accumulated when
extracts from cortex, medulla and papilla were incubated with 0.5
mM f3-NAD (Table 1 and Fig. 1); this amount of generated
cADPR (<0.3 nmol/60 mm/mg protein) cannot be reliably quan-
tified by the sea urchin bioassay (Table 1). On the other hand,
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Table 1. ADP-ribose cyclase activity in extracts from various rat organs, 22 —
renal tissue zones and nephron segments
N
cADPR synthesis
nmol/mg protein/60 mm
Tissue extract
Whole kidney 4 ND"
Liver 3 10 1.0'
Spleen 3 6.9 0.7
Heart 3 10.3 1.5
Brain 3 10.3 1.0
Renal tissues and nephron segments
Cortex 6 ND
Outer medulla 3 ND
Inner medulla 3 ND
Glomeruli 8 7.9 0.5
Proximal tubules 4 ND
(suspension)
Proximal convoluted tubules 3 ND
(microdissected)
Mesangial cells 3 2.5 0.1
Vascular smooth muscle cells 3 11.0 1
'Number denotes mean SEM
experiments
ND (quantity not determined) denotes rate of cADPR synthesis that
is below (0.3 nmol/mg protein) range of assay sensitivity required for
quantitations
of number of independent (N)
activity of cADPR-glycohydrolase was readily detected in extracts
from all three kidney tissue zones (Table 2). In contrast to extracts
from whole kidney and from the three kidney zones, incubation of
-NAD with extracts from other rat organs, namely heart, liver,
spleen, and brain, under the same conditions, showed a marked
accumulation of cADPR (Table 1).
Glomeruli and proximal tubules
In view of the observations that signaling functions can be
distinctly localized in specific segments and subsegments of the
nephron [26], we determined ADPR-cyclase activity in extracts
from isolated glomeruli and proximal tubules. Unlike extracts
from renal cortex, glomeruli showed high activity of ADPR-
cyclase (Table 1). However, activity of cADPR glycohydrolase was
similar in extracts from glomeruli and extracts from renal cortex
(Table 2). In contrast to glomeruli, virtually no ADPR-cyclase
activity was found in a suspension of isolated proximal tubules
(Table 2). Further, we examined segments of proximal convoluted
tubules that were microdissected from renal cortex, and similarly
to the suspension of proximal tubules isolated by the sieving-
Percoll gradient method, virtually no ADPR-cyclase activity was
detected (Table 1).
Characteristics of cADPR synthesis in glomeruli
Because glomeruli was found have a singularly high ability to
synthesize enzymatically a Ca2-releasing compound from
j3-NAD, we examined the authenticity of the cADPR synthe-
sized by glomeruli as an extract in more detail. Incubation of
13-NAD with heat-inactivated glonierular extract (data not shown)
and replacement of 13-NAD substrate by equimolar concentration
of stereoisomer a-NAD resulted in no synthesis of cADPR by
extract from glomeruli (Fig. 2). The cADPR synthesis by glomer-
ular extract was highly dependent on concentration of 13-NAD
substrate especially at concentrations of 0 to 0.2 mrvi NAD (Fig. 2).
I I I I I
10 20 30 40 50 60 70 80 90
Time, seconds
Fig. 1. Synthesis of c..4DPR by kidney cortex and glomendi. Whole cortex or
glomeruli extracts (1 mg protein/mi), prepared as described in the
Methods section, were incubated at 37°C in 0.25 M sucrose, 40 mtvi
Tris-HCI (pH 7.2) containing 0.5 m'vi 13-NAD for 60 minutes. Aliquots (3
to 6 xl) of assay media were tested for Ca2-release activity using the sea
urchin egg homogenate bioassay. The increase of Fluo-3 fluorescence
(ordinate, in arbitrary units) is proportional to Ca2 release triggered by
cADPR [2].
Renal tissue preparation nmol/mg protein/mm
Cortex 5 0.1
Outer medulla 6 0.2
Inner medulla 8 0.1
Glomeruli 6 0.1
Likewise, the cA.DPR synthesis was time-dependent (Fig. 3) and
proportional to the amount of glomerular extract protein (data
not shown). The activity of ADPR-ribosyl cyclase was prominently
inhibited by the addition of nicotinamide and DTT (Table 3),
compounds known to inhibit ADRP-ribosyl cyclase from other
vertebrate tissues [21.
The identity of cADPR generated by extract from glomeruli
was documented using several key criteria. Ca2'-releasing activity
of glomeruli extract incubated with j3-NAD, when tested in sea
urchin homogenate bioassay, was suppressed by the addition of
8-Br-cADPR [27], a specific antagonist of cADPR-triggered Ca2
Glomeruli
a)0
U)0(I)
U)0
0)0
U-
20 -
18 -
16 -
14 -
12 -
10
Cortex
Assay media
Table 2. Rate of inactivation of cADPR (cADPR glycohydrolase
activity) by extracts from renal tissues
For details of assay, see Methods.
Data are mean SEM of three independent experiments.
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NAD, mM
Fig. 2. Dependence of cADPR synthesis on concentration of NAD. Synthe-
sis of cADPR was determined as described in Figure 1, using different
Concentrations of -NAD (s), or a-NAD (•) as a substrate. Extracts
from glomeruli (1 mg protein/mi) were incubated with the substrate for 60
minutes, and the cADPR content determined using the sea urchin egg
homogenate bioassay, as described previously [10, 11, 23]. Cyclic ADPR
content was determined from calibration curve of the sea urchin egg
homogenate Ca2 release bioassay. The calibration curve was generated
by responses to known concentrations of authentic purified cADPR
standards.
release (Table 4 and Fig. 4). Also, both spermine and Mg2 which
inhibit both specifically cADPR-induced Ca2 release [2, 28, 29]
but not Ca2 release triggered by 1P3 or NAADP, a novel
Ca2-releasing nucleotide [23, 301, did block Ca21 release activity
evoked by incubation of glomerular extract with /3-NAD (Table
4). On the other hand, heparin, a well-established inhibitor of
1P3-induced Ca2 release [2] and thio-NADP, a specific inhibitor
of NAADP-dependent Ca2-release system [231, were without
effect upon the Ca2 release induced by the addition of 13-NAD
incubated glomeruli product.
The authenticity of cADPR generated by incubation of /3-NAD
with the extract from glomeruli was affirmed by homologous
desensitization of the bioassay system by cADPR, lack of heter-
ologous desensitization with 1P3 and NAADP (Fig. 5) and by
HPLC analysis (Fig. 6). Sea urchin egg homogenate Ca2 release
bioassay system displayed homologous desensitization to sequen-
tial additions of saturating concentrations of the same agent, but
neither 1P3 nor NAADP cross-desensitized the Ca2 release
response of the homogenate to the other agent [2, 23]. Incubation
of glomeruli extract with /3-NAD generated a compound that
induced Ca2 release when added to egg homogenates desensi-
tized to 1P3 and NAADP, but not when the egg homogenates were
desensitized to cADPR (Fig. 5). HPLC separation of the media
from glomeruli extract incubated with 0.5 mvt /3-NAD for three
hours, but not at 0 minutes, produced a peak that coeluted with
authentic cADPR (Fig. 6). These data, combined, document that
glomeruli contain enzymatic activity that is able to generate
cADPR when incubated with /3-NAD in the concentration range
found in cortical tissue [31 and microdissected glomeruli [19].
We also measured the rate of cADPR synthesis from 13-NAD in
extracts from mesangial cells and aortic VSMC grown in primary
4'
3 pi glomeruli + NAD
Fig. 3. Synthesis of cADPR by glomeruli. Glomeruli extracts (1 mg/mI)
were incubated with 0.5 mvt j3-NAD for various incubation periods, as
indicated. Aliquots (3 l) of assay media were tested for Ca2-release
activity using the sea urchin egg homogenate bioassay [2, 4, 10, ii]. This
Figure shows the time-dependent generation of cADPR.
Table 3. Effect of DTT and nicotinamide upon the rate of cADPR
synthesis by extract from glomeruli
Inhibition of cADPR synthesis
Additions as % of control
Control (no additions)
10 mM nicotinamide
1mMDYF 10±2
Control-specific activity of ADP-ribose cyclase in glomeruli (Table 1)
was taken as 100%. Each value is mean SEM of three experiments.
Table 4. Effect of specific antagonists of the three Ca2 release systems
[2, 23] upon the Ca2 release activity generated by incubation extract of
glomeruli with /3-NAD
Inhibitor (%) of Ca2 release activity
None 100
1 mg/mI heparin 100
10 /.M thio-NADP 100
4 rM 8-Br-cADPR 0
1 mM spermine 0
10 mM MgC12 0
a>
4-0
0>
0
E
cc
a-0
0
12
8
4
0
100 sec
0.0 0.2 0.4 0.6 0.8 1.0
a>0
a>0
Cl)
a>0
C,)0
U-
22 -
20 -
18 -
16 -
14 -
12 -
10 -
3 hr
2 hr
1 hr
0.5 hr
0 hr
100
4 0.5
culture. Both mesangial cells and VSMC showed a readily detect-
able and quite high rate of cADPR synthesis from /3-NAD (Table
1). These data raise the possibility that both types of examined
cells may be involved in cADPR generation in intact isolated
glomeruli.
1504 Chini et al. Cyclic ADP-ribose metabolism in glomeruli
Fig. 4. Functional identification of the metabolite of (3-WAD as cADPR.
The specificity of the Ca2 -releasing activity generated by incubation of
glomeruli extracts (1 mg protein/mi) with j3-NAD as cADPR was indicated
by the effect of 8-Br-cADPR, a specific inhibitor of the Ca2-release
induced by authentic cADPR in sea urchin egg homogenates. The Ca2
release was induced by the addition of 4 pi of glomeruh extracts incubated
with /3-NAD for 60 minutes, and the effect of inhibitor was determined by
preincubation of the egg homogenate with 4 /.LM 8-Br-cADPR for 20
seconds prior to the addition of the glonieruli incubate.
Discussion
The results of our study provide novel fundamental information
about the metabolism of cADPR, a nucleotide with specific
Ca2-releasing activity, in the kidney. We found that in kidney
parenchyma and its component, only glomeruli are endowed with
a high capacity for cADPR synthesis (Table 1). In extracts from
kidney tissue as a whole or from the three major kidney zones
ADPR-cyclase is only marginally detectable, unlike in extracts
from brain, heart, liver, and spleen (Table 1). Interestingly, in an
early study, Rusinko and Lee [7] investigated extracts from several
rabbit tissues and observed that extracts from whole rabbit kidney
had the lowest capacity to generate cADPR from /3-NAD.
Extract from glomeruli isolated from cortical tissue showed a
very high capacity for cADPR synthesis in the range of ADPR-
cyclase activities found in non-renal tissues (Table 1 and Fig. 1).
In contrast, proximal tubules have virtually no ADPR-cyclase
activity, and this finding is in accord with measurements of
cADPR synthesis in microdissected proximal convoluted tubules
(Table 1). Lack of appreciable cADPR accumulation in renal
cortical extract cannot be accounted for by unusually high specific
activity of cADPR glycohydrolase causing rapid hydrolysis of
cADPR, as it is the case of renal metabolism of NAADP, another
Ca2treleasing adenine nucleotide diphosphate [281, since activ-
ities of cADPR glycohydrolase are about the same in extracts
from cortical tissue and from glomeruli (Table 2). Glomeruli
constitute only 5% of renal cortical mass [31, 321. A possibility
should thus be considered that the lack of appreciable cADPR
accumulation in cortical extract incubated with /3-NAD may be
due to an imbalance between the small contribution of high
ADPR-cyclase activity from glomeruli and a large (95%) propor-
Fig. 5. Desensitization of the sea urchin egg homogenate bioassay. The
properties of the Ca2-releasing activity generated by incubation of
p-NAD with glomerular extracts as cADPR were indicated by homolo-
gnus desensitization of the sea urchin egg homogenate bioassay. Homol-
ogous desensitization was determined by sequential additions. The first 4
il of assay media from glomeruli extracts incubated with NAD for one
hour was added. After that, Ca2 release and re-uptake of Ca2 subse-
quent additions of 120 nri cADPR, then 120 nM NAADP, and finally 4 jM
1P3 were added to the sea urchin egg homogenate as indicated.
tion of total cADPR-glycohydrolase activity in renal cortical
extract (Table 2). In other words, a relatively high total activity of
cADPR-glycohydrolase in the extract from renal cortical tissue
may inactivate cADPR synthesized by a far lesser total activity of
ADPR-cyclase contributed by glomeruli. It should be also consid-
ered that cells of glomeruli and cells of surrounding tissues may be
endowed with different types of ADPR cyclases [1, 2], and these
can be expressed to a different extent. For example, some
membrane-bound enzymes are bifunctional and have both ADPR
cyclase and cADPR glycohydrolase activities, and cADPR glyco-
hydrolase activity is manyfold higher than the cyclase activity [1, 2,
13, 14]. It is thus conceivable that cells of tubules, but not of those
of glomeruli, contain an enzyme of this nature.
Our findings show that proximal tubules, which constitute about
50% of renal cortical mass [31, 32], are virtually devoid of
ADPR-cyclase. In view of aforementioned considerations, it
cannot be excluded that substantial ADPR-cyclase activity may
exist in some nephron segment(s) other than glomcruli or other
cells occurring in cortex, and the same consideration applies to
outer and inner medulla. However, in such case ADPR-cyclase is
likely present in sharply localized nephron segment(s), which
comprise a small portion of renal cortex mass [26, 31, 321.
Determination of cADPR with use of sea urchin homogenate
Ca2-release assay is well accepted and a widely used method [1,
2, 10, 11, 23, 29]. However, in view of the potential importance of
high ADPR-cyclase activity found in glomeruli, the authenticity of
cADPR synthesized from /3-NAD was rigorously recommended
with the use of several major criteria [2], which include: specific
inhibition of cADPR action by agents known to selectively block
Ca2 release triggered by this nucleotide, HPLC anion exchange
50 sec
8-Br-cADPR (l.IM)
ci>0C
a)0(I)
a>0
C,)0
U-
26 -
24 -
22 -
20 -
18 -
16 -
14 -
12 -
ci>0C
ci)0
U)
ci)0
C')
0
U-
24
20
16
12
8-
0.0
4.0
,__00 sec
140 I
Assay media
I P3
Assay media NAADP
cADPR
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Fig. 6. HPLC analysis of Ca2 '-releasing metabolite generated from /3-NAD.
Glomerular extracts (1 mg/mI) were incubated with 0.5 mv [3H] 13-MAD
(1 sCi) for three hours, as described in Figure 1. The reaction was stopped
by the addition of equal volumes of cold acetone and centrifuged 2,000 g
for two minutes at 4°C. After acetone evaporation, the supernatant was
subjected to anion-exchange HPLC analysis (Methods). The HPLC
analysis of incubate prior to incubation is shown at time 0 minutes (LII),
and after three hours (•) of incubation as described above. Detected
peaks (254 nm ultraviolet) were identified by coelution with authentic
standards. Ca21 release activity of each sample was tested using the sea
urchin egg homogenate bioassay. The Ca2 releasing activity was detected
solely in the cADPR peak of the three hours incubate corresponding to
the retention time of authentic cADPR. NiAm denotes nicotinamide. The
ordinate is [3H-radioactivity of substrate 13-NAD and products; the
abscissa represents the time of elution (mm).
chromatographic analysis, stereospecificity of f3-NAD as a sub-
strate and homologous desensitization of Ca2 release activity in
cADPR bioassay [2, 4, 10, 23, 29]. Similarly, as in other vertebrate
cell types, glomeruli ADPR cyclase was inhibited by nicotinamide
and by Dli [2].
With respect to the site of cADPR synthesis in glomeruli, it is
of interest that extracts from mesangial cells and VSMC grown in
primary culture showed a significant rate of cADPR synthesis
(Table 1). Projection of the findings on cells grown in vitro to cells
in vivo should be made with due caution, since in cultured cells
some biochemical components may appear that are not expressed
in native cells in vivo. With this reservation in mind, our findings
indicate that mesangial cells that are present in glomeruli and
VSMC in adjacent arterioles (which remain attached to some
isolated glomeruli) may be sites of cADPR synthesis and can
contribute to cADPR synthesis by the extract from glomeruli.
Glomerular epithelial cells, although specifically differentiated,
have similar embryologic origin as cells of proximal convoluted
tubules [33, 34] and are contiguous with early proximal convoluted
tubules. Hence, it might not be surprising to find that, as in the
case of cells of proximal convoluted tubules, glomerular epithelial
cells may have little or no ADPR-cyclase activity. Possible roles of
endothelial cells of glomerular capillaries also remain to be
determined. However, the precise localization of cADPR metab-
olizing enzymes in cells that populate glomeruli ought to be
investigated using methods such as in situ hybridization and
immunocytochemistry.
The potential for the regulatory function of cADPR in glomer-
uli will be briefly discussed. It is noteworthy that, similar to what
was observed in studies on OK cells [11], in the lower range of
13-NAD concentrations the rate of glomerular cADPR synthesis is
highly dependent (Fig. 2) on the substrate level, especially at
concentrations <0.2 mvt. In preceding studies we determined that
NAD levels, as determined in snap-frozen renal cortex, are in the
range of 0.5 to 0.6 m'vi [30, 35]. Measurement of NAD in
microdissected nephron segments indicate that NAD level in
glomeruli is about 2.5-fold lower than in cortical tubules [19].
Providing that these findings reflect or approximate NAD levels in
intact tissue in situ, changes in the metabolic state of glomerular
cells that can determine intracellular concentration of free oxi-
dized /3-NAD [36, 37] may thereby modulate the rate of cADPR
synthesis and cADPR-controlled Ca2 release through RyR.
Therefore, the cADPR system may subserve as an intracrine
signaling pathway through which the metabolic state of the cell
modulates other cell functions [15].
Further, cADPR has a potential role as a second messenger in
response to hormones that act via genomic mechanism [10] or via
membrane receptors [38]. In view of this, actions of hormonal
agents and autocoids that are known to regulate glomerular cell
functions should be investigated to determine whether their
regulatory effects may be mediated in part via the cADPR
signaling system in glomerular cells. With respect of cADPR
generated within mesangial cells and VSMC, levels of cADPR
might regulate Ca2 ' release from intracellular stores and contrac-
tility [38—40], and thereby possibly modulate blood flow and
filtration rate in glomerulus. It has been reported that in VSMC
[39], cardiomycytes [40] and intestinal smooth muscle cells [38]
cADPR can trigger Ca24 release. Thus, glomerular cell contrac-
tility and other functions in glomeruli could be regulated by
cADPR via modulation of Ca2 release in response to metabolic
and hormonal stimuli [10, 15] akin to regulations via similar but
distinct IP3-Ca2 release pathway [1—3].
In conclusion, we determined basic characteristics of hitherto
unknown cADPR metabolism in rat kidney, and our results reveal
localization of cADPR synthesis in glomeruli with potential
implications for cellular signaling and regulation of glomerular
cell function. The results also indicate that the cADPR signaling
system ought to be studied in specific nephron segments and
surrounding structures.
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